PARAMETERS CONTROL (n = 45) CAD n = (46) P
Age [years] 45.8 ± 15.0 46.1 ± 14.0 0.167
Gender (M)[%] 54.7 53.3 0.894
Obesity [%] 14.6 28.3 0.125
Hypertension [%] 4.8 36.9 <0.001
Fasting plasma glucose [mg/dl]a 84.4  ± 6.6 95.30  ± 32.1 0.034
Glycated hemoglobin [%] 5.5  ± 0.5 6.1  ± 1.2 0.010
Diabetes [%] - - NA
Serum total cholesterol [mg/dl]a 174.1  ± 29.6 193.0  ± 59.6 0.066
Serum triglyceride [mg/dl]a  85.0 ± 36.3 113.2  ± 57.1 0.008
High density Lipoprotein ((HDL) [mg/dl]a 46.5 ± 8.6 45.7 ± 11.7 0.741
Low density Lipoprotein (LDL) [mg/dl]a 110.0 ± 27.5 124.6 ± 54.1 0.136
Dyslipidemia[%] 42.9 58.7 0.138
HOMA-IRa 1.1 ± 0.6 1.7 ± 1.1 0.003
hs-CRP [mg/L] (geo mean) 1.28 3.24 0.029
LPS activity (geo mean) 0.21 1.01 <0.001
Smoking [%] 35 24 0.226
Metabolic syndrome [%] 2.4 29.5 0.001
aFor FPG, STC, STL, HDL, LDL and HOMA-IR mean ± SD is reported
Table 1: Clinical characteristics of the study subjects.